Iterum Therapeutics PLC (ITRM)
1.19
+0.04
(+3.48%)
USD |
NASDAQ |
Jun 01, 16:00
1.25
+0.06
(+5.04%)
After-Hours: 20:00
Iterum Therapeutics Enterprise Value: -6.286M for June 1, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 01, 2023 | -6.286M |
| May 31, 2023 | -6.804M |
| May 30, 2023 | -6.962M |
| May 26, 2023 | -6.998M |
| May 25, 2023 | -6.416M |
| May 24, 2023 | -4.345M |
| May 23, 2023 | -6.416M |
| May 22, 2023 | -6.804M |
| May 19, 2023 | -6.923M |
| May 18, 2023 | -7.450M |
| May 17, 2023 | -7.192M |
| May 16, 2023 | -7.192M |
| May 15, 2023 | -7.038M |
| May 12, 2023 | -6.934M |
| May 11, 2023 | -7.063M |
| May 10, 2023 | -6.804M |
| May 09, 2023 | -7.322M |
| May 08, 2023 | -7.321M |
| May 05, 2023 | -7.192M |
| May 04, 2023 | -7.710M |
| May 03, 2023 | -7.063M |
| May 02, 2023 | -7.451M |
| May 01, 2023 | -6.675M |
| April 28, 2023 | -6.705M |
| April 27, 2023 | -8.050M |
| Date | Value |
|---|---|
| April 26, 2023 | -8.882M |
| April 25, 2023 | -8.562M |
| April 24, 2023 | -7.858M |
| April 21, 2023 | -7.986M |
| April 20, 2023 | -7.217M |
| April 19, 2023 | -6.449M |
| April 18, 2023 | -6.833M |
| April 17, 2023 | -6.321M |
| April 14, 2023 | -6.577M |
| April 13, 2023 | -7.823M |
| April 12, 2023 | -8.882M |
| April 11, 2023 | -9.126M |
| April 10, 2023 | -9.010M |
| April 06, 2023 | -9.264M |
| April 05, 2023 | -9.010M |
| April 04, 2023 | -8.754M |
| April 03, 2023 | -9.269M |
| March 31, 2023 | -8.884M |
| March 30, 2023 | -19.71M |
| March 29, 2023 | -20.03M |
| March 28, 2023 | -20.28M |
| March 27, 2023 | -20.41M |
| March 24, 2023 | -20.16M |
| March 23, 2023 | -20.28M |
| March 22, 2023 | -19.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-32.41M
Minimum
Sep 26 2018
394.05M
Maximum
Feb 10 2021
45.06M
Average
36.85M
Median
Oct 25 2021
Enterprise Value Benchmarks
| Alkermes PLC | 4.556B |
| Jazz Pharmaceuticals PLC | 12.82B |
| Perrigo Co PLC | 7.887B |
| Horizon Therapeutics PLC | 23.17B |
| Mallinckrodt PLC | 2.640B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.889M |
| Total Expenses (Quarterly) | 8.53M |
| EPS Diluted (Quarterly) | -0.78 |
| Earnings Yield | -350.4% |
| Normalized Earnings Yield | -8344.54 |